NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Novasep gained FDA approval last year for an expansion of its highly potent active pharmaceutical ingredients (HPAPI) capabilities at its plant in Le Mans, France. Now the French contract manufacturer is planning to build a facility there capable of manufacturing antibody drug conjugates (ADCs). The company today said it will…

news

Bristol-Myers Squibb is calling it quits with its virology R&D program – a move that undoubtedly will impact its early stage scouting and acquisition efforts. This largely impacts its early work in hepatitis B and HIV therapies, though it won’t affect the virology therapies currently in development or on the…

news

Shanghai Jahwa United Co Ltd Says in deal with Zhangzhou Pientzehuang Pharma to set up JV with registered capital at 190 million yuan ($30.61 million).   reuters.com

news

The U.S. Centers for Disease Control and Prevention on Wednesday recommended that decisions to use new meningitis B vaccines from Pfizer and GlaxoSmithKline in people aged 16 to 23 be made on an individual patient basis by physicians, the companies said, potentially paving the way for wider access to the…

news

Hospira Inc, the generic injectables firm acquired by Pfizer recently, has received the US Food and Drug Administration (FDA)’s nod to manufacture finished dosage drugs at its Visakhapatnam facility in Andhra Pradesh. It may be noted that the US regulator has issued a Form 483, notifying the company management of…

news

Hybio Pharmaceutical Says in deal with Tencent on building online service platform for diabetes and chronic diseases. Says trading of shares to resume on June 25.   reuters.com

news

Canadian biotech Clementia Pharmaceuticals raised $60 million in mezzanine cash to help it fashion a once-failed Roche ($RHHBY) drug into a promising treatment for a rare disease. VC giant New Enterprise Associates stepped in to lead the latest round, joined by new investors including UCB, RA Capital Management and Rock…

news

Daiichi Sankyo Company, Limited and Maruishi Pharmaceutical Co., Ltd. (hereafter, Maruishi Pharmaceutical) today announced a collaboration to commercialize the general anaesthesia analgesic, Remifentanil injection generic, for which Maruishi Pharmaceutical is currently applying for a manufacture and marketing license. Remifentanil injection is widely used as an opioid analgesic (μ-opioid receptor agonist)…

news

Drug firm Zydus Cadila has received approval from the US health regulator to market its Pyridostigmine Bromide Tablets, used for treating various neurological disorders. With this approval, the group has received 100 approvals and has so far filed 260 ANDAs (abbreviated new drug applications). The company has received final approval…

news

Drug firm Jubilant Life Sciences has received approval from the US health regulator to market generic levofloxacin tablets, used to treat various infections including pneumonia. The company has received approval from the US Food and Drug Administration (USFDA) to market generic version of Levaquin tablets in strengths of 250 mg…